Final-Program-ATS-2023-AP.vp

SUNDAY • MAY 21

105

Chairing: M.M. Freemer, MD, MPH, Bethesda, MD 12:00 Asthma among Dine children living on the Navajo Nation B.G. Bender, PhD, Denver, CO 12:15 Asthma among West Philadelphia Asthma Care Collaborative (WePACC) participants T. Bryant-Stephens, MD, Philadelphia, PA 12:30 Asthma among RVA Breathes participants R.S. Everhart, PhD, Richmond, VA 12:45 Asthma among Rhode Island Asthma Integrated Care (RI AIR) participants D. Koinis-Mitchell, PhD, Providence, RI R Pre-registration and additional fees required. Attendance is limited. $100 Member/Non-Members $70 LMIC Member/LMIC Non-Members 12:00 p.m. - 1:00 p.m Marriott Marquis Washington MTE7 INTERSTITIAL LUNG DISEASE IN ANCA VASCULITIS M. Baqir, MBBS, Rochester, MN R. Krishna, MBBS, Charleston, SC University of DC/Catholic University (Level M1) MTE8 MITIGATING DISPARITIES IN THE LUNG CANCER SCREENING PIPELINE F.C. Duncan, MD, MS, Indianapolis, IN S.B. Ogake, MD, Plain City, OH E.R. Nunez, MD, Boston, MA Howard University (Level M1) MTE9 PEDIATRIC INVASIVE VENTILATION: MANAGEMENT AND RESOURCE CONUNDRUMS D. Liptzin, MD, MS, Missoula, MT Georgetown University (Level M1) MTE11 SMALL AIRWAYS DISEASE: WHEN IT’S NOT ASTHMA S.J. Callahan, MD, Salt Lake City, UT M. Koslow, MD, Denver, CO R. De Oliveira Duarte Achcar, MD, Denver, CO B. Elicker, MD, Novato, CA Chinatown (Level M3) MTE13 MEDIA & ME: HOW TO COMMUNICATE SCIENCE AND HEALTH THROUGH DIFFERENT MEDIA SOURCES S.C. Sadreameli, MD, MHS, Baltimore, MD P. Galiatsatos, MD, Baltimore, MD LeDroit Park (Level M3) F. Afolabi, MD, Dallas, TX C.D. Baker, MD, Aurora, CO A.S. Gelfand, MD, Dallas, TX MEET THE EXPERT SEMINARS CME Credits Available: 1

Chairing: G. Zhou, PhD, Bethesda, MD M. Pieck, PHD, Bethesda, MD 12:00 Introduction to the Catalyze Program M. Pieck, PhD, Bethesda, MD 12:10 Optimization of PET Probe for Imaging Lung Fibrogenesis P.D. Caravan, PhD, Charlestown,, MA 12:20 Bedside Tomosynthesis Imaging for ICU Patients O. Zhou, PhD, Chapel Hill, NC 12:30 Therapeutic Targeting a Ubiquitin E3 Ligase to Control Pulmonary Inflammation R.K. Mallampalli, MD, Columbus, OH 12:40 Panel Discussion G. Zhou, PhD, Bethesda, MD COMMUNITY RESULTS FROM ASTHMA EMPOWERMENT COLLABORATIONS TO REDUCE CHILDHOOD ASTHMA DISPARITIES 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 145 A-B (Street Level) Target Audience stakeholders engaged with children with asthma (e.g., health care providers, public health officials, municipal leaders, care givers) Objectives At the conclusion of this session, the participant will be able to: • to assess which interventions affected asthma outcomes in communities with children at high risk for poor outcomes. • to understand why an evidence based intervention may need to be tailored for a specific community. • to consider how asthma care for children can be coordinated among a variety of providers. In 2017, NHLBI funded 4 groups of investigators to conduct multi-level clinical trials to provide comprehensive asthma care within communities where children were at high risk for poor asthma outcomes. The trials were designed with evidence based interventions targeted to address findings from a formal needs assessment in each community. Key aspects of these trials included the integration of asthma care for the children and their families as well as efforts to facilitate the sustainability of the programs after the conclusion of the trials. Investigators will briefly review the protocols conducted in each community and provide the available results as most of these multi-year trials were recently completed. The assessment of the sustainability of the programs will be conducted in the future. DIVISION OF LUNG DISEASES, NHLBI/NIH OUTSIDE ORGANIZATION SESSION L6

ATS 2023 • Washington, DC